Evidence map›Paper›PMID 22438666›Full record

ArticlePharmacognosy magazine2012

Antihyperglycemic and antihyperlipidemic effects of guar gum on streptozotocin-induced diabetes in male rats.

Saeed Samarghandian, Samarghandian Saeed, Mosa-Al-Reza Hadjzadeh, Hadjzadeh Mosa-Al-Reza, Fatemeh Amin Nya, Amin Nya Fatemeh, Saeideh Davoodi, Davoodi Saeideh

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Pharmacognosy magazine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Dietary Fiber: An Opportunity for a Global Control of Hyperlipidemia.Oxidative medicine and cellular longevity · 2021
    Review
  3. Article
  4. Insight in the Recent Application of Polyphenols From Biomass.Frontiers in bioengineering and biotechnology · 2021
    Review
  5. The Antioxidant Activities ofAntioxidants (Basel, Switzerland) · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

  • Erratum issued
    Saeed, Samarghandian [corrected to Samarghandian, Saeed; Mosa-Al-Reza, Hadjzadeh [Hadjzadeh, Mosa-Al-Reza]; Fatemeh, Amin Nya [corrected to Amin Nya, Fatemeh]; Saeideh, Davoodi [corrected to Davoodi, Saeideh]
5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Saeed SamarghandianHealth Research Strategic Center, Neyshabur Faculty of Medical sciences, Neyshabur, Iran [corrected].
Samarghandian Saeed
Mosa-Al-Reza Hadjzadeh
Hadjzadeh Mosa-Al-Reza
Fatemeh Amin Nya
Amin Nya Fatemeh
Saeideh Davoodi
Davoodi Saeideh
Mashhad University of Medical Sciences · IRIslamic Azad University, Mashhad · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHerbal medicine is widely used in the treatment of diseases like diabetes mellitus. We investigated the effects of guar gum in diabetic rats for the reduction of the risk of diabetes and cardiovascular disease. Dietary pattern emphasizing foods high in complex carbohydrates and fiber are associated with low blood glucose and cholesterol levels. MATERIALS AND

methodsDiet containing 0%, 5%, 10% and 20% (w/w) guar gum was fed to diabetic rats for 28 days. Blood serum glucose, triglycerides, cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol levels, atherogenic index levels, body weights and food intake were monitored at 0, 7.14 and 28 days after induction of diabetes.

resultsIn spite of the fact that diabetes elevated blood lipids in all rats after 14 days, the guar gum diet significantly decreased the serum concentration of cholesterol, triacylglicerols and LDL-C and atherogenic index. The most significant result in this study was the reduction of blood glucose in diabetic rats treated with the guar gum diet after 28 days versus non- and glibenclamide-treated rats. The gum promoted a general improvement in the condition of the diabetic rats in body weight and food intake in comparison with nontreated rats.

conclusionThe results of this research suggest that guar gum was significantly effective in comparison with glibenclamide in the treatment of hyperlipidemia and hyperglycemia in diabetes rats. Therefore, it may be suggested as a reliable fiber in diabetic regimes in diabetic patients.

Indexed as

diabetes mellitusDietary fiberguar gumlipid profilerat

Identifiers

PMID22438666
PMCPMC3307206
OpenAlexW2098743913

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.